logo-loader
viewGlaxoSmithKline PLC

GSK sells two vaccines for up to €1bn

The company said it decided to sell these brands to focus on other segments within its fast-growing vaccines business

GlaxoSmithKline PLC - GSK sells two vaccines to Bavarian Nordic for up to €955mln
Rabipur and Encepur are administered to prevent rabies and tick-borne encephalitis, respectively

GlaxoSmithKline PLC (LON:GSK) (NYSE:GSK) has agreed to sell two travel vaccines to Danish biotech firm Bavarian Nordic for up to €955mln.

Rabipur and Encepur are administered to prevent rabies and tick-borne encephalitis, respectively.

READ: GSK recalls heartburn drug over carcinogen risk

Bavarian Nordic will pay €301mln up front, plus an instalment of €495mln and an estimated €159mln in additional revenues over the course of the supply arrangements.

GSK said it decided to sell these brands, acquired in 2015, to focus on other segments within its vaccines business.

“This agreement with Bavarian Nordic will enable us to commit greater resources to our key growth assets and to our research & development pipeline, while also ensuring the continued supply of these important and successful vaccines,” said Roger Connor, president at global vaccines at GSK.

Vaccines have been GSK's star performer in both quarters so far this year, with second-quarter sales soaring by more than a quarter to £1.59bn as demand for the Shingrix shingles treatment continuing to rise, while sales of HIV drugs were solid but growth was much slower in the pharmaceuticals arm.

The drugs giant in August sold off its consumer health business, which includes brands such as Sensodyne and Nicorette, into a 68%-owned joint venture deal with US rival Pfizer Inc (NYSE:PFE).

Quick facts: GlaxoSmithKline PLC

Price: 1699.8 GBX

LSE:GSK
Market: LSE
Market Cap: £84.8 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Stobart Group PLC reports ' strong strategic and operational first-half...

Stobart Group (LON:STOB) CEO Warwick Brady and CFO Lewis Girdwood highlight what they believe to be the 'significant growth potential' within its aviation division and in particular at London Southend airport. Passenger numbers at the airport increased by 41.8% to 1.2 million in the six...

2 days, 9 hours ago

RNS

Director/PDMR Shareholding

5 days, 9 hours ago

Director/PDMR Shareholding

1 week, 3 days ago

Director/PDMR Shareholding

1 week, 5 days ago

Director/PDMR Shareholding

2 weeks, 3 days ago

Total Voting Rights

2 weeks, 3 days ago

Director/PDMR Shareholding

2 weeks, 4 days ago

Director/PDMR Shareholding

2 weeks, 5 days ago

2 min read